captodayonline
The Food and Drug Administration in 2017 approved MALDI-TOF mass spectrometry for the identification of mycobacteria. What is the protocol? How is workflow affected? Are there cost savings and turnaround time improvements? Omai Garner, PhD, D(ABMM), answered these and other questions and shared his laboratory’s validation data in a Dec. 13, 2018 CAP TODAY webinar supported by Bio¬Mérieux (captodayonline.com). Here is an edited transcript of what he said.
Watch Now
Abcam plc
Watch this on-demand webinar presented by Dr. Akihiko Takashima and Dr. Ioannis (John) Sotiropoulos and learn about the emerging views on the role and function of Tau in neurons - including its recently suggested contributions to scaffolding and signaling.
Watch Now
Amid a growing number of cell therapies reaching late-stage clinical studies and commercial launch, the considerations required to deliver scalable commercial manufacturing, including meeting reduced timelines and the increased demand for capacity, are critical to getting these cell products to patients.
Watch Now
Pharmaron has taken their platform beyond small molecules and are pleased to now offer a full array of services for biologics and cell and gene therapies (CGTs). Our new CGT webinar series focusses on identifying key cell and gene therapy questions that arise during drug discovery and development.
Watch Now